Journal of ISSN: 2373-6437JACCOA

Anesthesia & Critical Care: Open Access
Mini Review
Volume 4 Issue 5 - 2016
A Theory of Mechanism and Nomenclature of Neuromuscular Blocking Drugs
Fadhil Zwer*
Consultant Intensive Care Medicine at Private practice clinic, Iraq
Received: March 06, 2016 | Published: April 05, 2016
*Corresponding author: Fadhil Zwer, Consultant Intensive Care Medicine at Private practice clinic, Iraq,Email:
Citation: Zwer F (2016) A Theory of Mechanism and Nomenclature of Neuromuscular Blocking Drugs. J Anesth Crit Care Open Access 4(5): 00156. DOI:10.15406/jaccoa.2015.04.00156

Mini Review

After practicing anesthesiology and intensive care medicine for about 35 years my idea is: commonly the neuromuscular blocking drugs are classified as:

  1. Depolarizing neuromuscular blocking drugs.
  2. Nondepolarizing neuromuscular blocking drugs.

Really, regarding the mechanism of action of these drugs (Figures 1 & 2), this classification and nomenclature is being to some extent incorrect. Regarding the nondepolarizing neuromuscular blocking drugs there will be a certain way that the drug is blocking ionic channel of nicotinic receptor and by closing the receptor [blocked] no ion exchange will occur and no action potential will initiated and progressed, leading the muscle to be relaxed. However, when dealing with depolarizing drugs, their action on neuromuscular nicotinic receptor is differs completely, as these drugs seems to depolarize the receptor make it opened like the ligand acetylcholine, and ion exchange will occur but as action of depolarizing drugs is much longer than the ligand (minutes versus milliseconds) then a some type of no ion exchange will further occurs [equilibration or inactivation of voltage-gated sodium channels] the condition indeed some call it desensitization, when equilibration of ions occur then no further action potential will be initiated and the muscle therefore relax [not because of block but instead because of prolonged receptor state of opening]. In this case depolarizing drugs cannot consider as blocking drugs, rather than like if the acetylcholine prolonged its action. Therefore, I believe it is more logical and accurate to change the classification of neuromuscular blocking drugs as follow:

  1. Depolarizing neuromuscular relaxing [non-blocking] drugs.
  2. Nondepolarizing neuromuscular blocking drugs.

Figure 1: The mechanism of blocking of neuromuscular nicotinic receptor by antagonist (nondepolarizing block).

Figure 2: Depolarizing drugs act to open the nicotinic receptor channel and keeping it opened the condition which leading to equilibration of ion exchange through the channel and therefore no further depolarization occurred.

© 2014-2016 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://medcraveonline.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy